Lithium Carbonate Er | Lithium Carbonate Tablet Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Lithium Carbonate Er | Lithium Carbonate Tablet is safe in breast-feeding or not.

What is Lithium Carbonate Er | Lithium Carbonate Tablet used for?


Lithium Carbonate Extended-Release Tablets are indicated in the treatment of manic episodes of manic-depressive illness. Maintenance therapy prevents or diminishes the intensity of subsequent episodes in those manic-depressive patients with a history of mania. Typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness and possibly hostility. When given to a patient experiencing a manic episode, Lithium Carbonate Extended-Release Tablets may produce a normalization of symptomatology within 1 to 3 weeks.

Is using Lithium Carbonate Er | Lithium Carbonate Tablet unsafe in breastfeeding? Can there be bad consequences for baby if I use it while breastfeeding?

Lithium Carbonate Er | Lithium Carbonate Tablet high risk while breastfeeding
As Lithium Carbonate Er | Lithium Carbonate Tablet is made of only Lithium carbonate, and Lithium carbonate is unsafe to use in breastfeeding we can safely reach on conclusion that Lithium Carbonate Er | Lithium Carbonate Tablet is also unsafe to use while breastfeeding. Below is detailed analysis of Lithium carbonate and Lithium Carbonate Er | Lithium Carbonate Tablet during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Statement of Manufacturer/Labeler about breastfeeding usage
Usage in Nursing Mothers Lithium is excreted in human milk. Nursing should not be undertaken during lithium therapy except in rare and unusual circumstances where, in the view of the physician, the potential benefits to the mother outweigh possible hazards to the infant or neonate. Signs and symptoms of lithium toxicity such as hypertonia, hypothermia, cyanosis, and ECG changes have been reported in some infants and neonates.
Usage in Nursing Mothers Because of the potential for serious adverse reactions in nursing infants and neonates from lithium, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother (see WARNINGS).

Lithium Carbonate Er | Lithium Carbonate Tablet Breastfeeding Analsys


Lithium carbonate while Breastfeeding

Unsafe

CAS Number: 554-13-2

It is excreted into breast milk in amounts that may be clinically significant and can be as high as a half of that reached in mother’s plasma and up to one third of the therapeutic level in the infant. In infants and newborns (5 days), premature babies and dehydrated or infected infants, who may show reduced clearance mechanisms for lithium, there have been reports of clear signs of lithium toxicity caused by ingestion of breast milk: cyanosis, lethargy, hypotonia or slight increase in TSH. However, there are numerous cases of infants whose mothers were on lithium who did not show any clinical, growth or neurodevelopmental problem at the short or long term. Breastfeeding is less risky for healthy term infants whose mothers are treated with lithium when she or her family has capacity enough to monitor the occurrence of adverse effects, medical supervision and, whenever necessary, monitoring of lithium levels in the mother-infant dyad. Mothers should stop taking lithium 1 to 2 days before delivery or cesarean section in order to decrease plasma levels in the newborn. Lithium may be, or not, a cause of increased Prolactin and galactorrhea.


Lithium Carbonate Er | Lithium Carbonate Tablet Breastfeeding Analsys - 2


Lithium carbonate while Breastfeeding

CAS Number: 554-13-2

Although lithium appears on many lists of drugs contraindicated during breastfeeding, other sources do not consider it an absolute contraindication, especially in infants over 2 months of age and during lithium monotherapy.[1][2][3][4] Numerous reports exist of infants who were breastfed during maternal lithium therapy without any signs of toxicity or developmental problems. Most were breastfed from birth and some continued to nurse for up to 1 year of maternal lithium therapy. Limited data suggest that lithium in milk can adversely affect the infant when its elimination is impaired, as in dehydration or in newborn or premature infants. Neonates may also have transplacentally acquired serum lithium levels. Because maternal lithium requirements and dosage may be increased during pregnancy, maternal serum levels should be monitored frequently postpartum and dosage reduced as necessary to avoid excessive infant exposure via breastmilk.[5] The long-term effects of lithium on infants are not certain, but limited data indicate no obvious problems in growth and development.[6] Lithium may be used in mothers of fullterm infants who are willing and able to monitor their infants. Discontinuing lithium 24 to 48 hours before Cesarean section delivery or at the onset of spontaneous labor and resuming the prepregnancy lithium dose immediately after delivery should minimize the infant's serum lithium concentration at birth.[7] Some investigators recommend monitoring infant serum lithium, serum creatinine, BUN, and TSH in intervals ranging from "periodic" to every 4 to 12 weeks during breastfeeding and maternal lithium therapy.[3][8][9] However, others recommend close pediatric follow-up of the infant and only selective laboratory monitoring as clinically indicated.[7] Breastfeeding should be discontinued immediately and the infant evaluated if the infant appears restless or lethargic or has feeding problems.[7]



I am nursing mother and I have already used Lithium Carbonate Er | Lithium Carbonate Tablet, what should I do?

We have already established that Lithium Carbonate Er | Lithium Carbonate Tablet is unsafe in breastfeeding and breastfeeding while using Lithium Carbonate Er | Lithium Carbonate Tablet is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


My health care provider has asked me to use Lithium Carbonate Er | Lithium Carbonate Tablet, what to do?

If your doctor knows that you are breastfeeding mother and still prescribes Lithium Carbonate Er | Lithium Carbonate Tablet then there must be good reason for that as Lithium Carbonate Er | Lithium Carbonate Tablet is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Lithium Carbonate Er | Lithium Carbonate Tablet, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Lithium Carbonate Er | Lithium Carbonate Tablet and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Lithium Carbonate Er | Lithium Carbonate Tablet in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week